FDA
-
ECRI, Plymouth Meeting, Reports on Medical Technology Fails; One Is Both Dangerous and Pervasive
A QMED article cites data from ECRI, the Plymouth Meeting healthcare safety nonprofit, warning about a pervasive medical risk. QMED’s…
-
Conshohocken-based Madrigal Pharmaceuticals’ Shares Skyrocket Following Liver Disease Clinical Trial
Conshohocken-based Madrigal Pharmaceuticals saw its shares leap in value after the company reported additional positive late-stage clinical trial data for…
-
Collegeville Bioengineering Student Spent Summer Internship at the Food and Drug Administration
Collegeville resident Prem Ganesh, a senior bioengineering student at Temple, is back in on campus now. But he’s brought a…
-
CHOP Receives Generous Gift from Main Line Couple to Establish Cancer Immunotherapy Center
Philanthropists Susan and Steve Kelly, longtime supporters of the Children’s Hospital of Philadelphia (CHOP), are helping establish the Susan S.…
-
Analytical Testing Services Laboratory in King of Prussia Aims to Add Jobs, Address Needs for Cell, Gene Therapy
The new analytical testing services laboratory opened by the Center for Breakthrough Medicines at the Discovery Labs complex in King…
-
Main Line CEO Scott Braunstein Makes Top 25 Biotech CEO List
The CEO of a Radnor-based pharmaceutical company, Dr. Scott Braunstein, M.D., has made a top 25 list of Biotech CEOs…
-
Merck’s Experimental COVID-19 Pill is Less Effective Than Predicted by Early Clinical Trials
The experimental COVID-19 pill developed by Merck, the pharmaceutical giant with sizable operations in West Point, and its partner Ridgeback…
-
CDC: Pfizer COVID-19 Vaccine 93 Percent Effective at Protecting Teens from Hospitalization
A new study by the Centers for Disease Control and Prevention (CDC) found the Pfizer COVID-19 vaccine to be 93…
-
Merck Drug One Step Closer to Becoming First At-Home COVID-19 Treatment
A COVID-19 pill created by Merck, the pharmaceutical giant with sizable operations in West Point, and Ridgeback Biotherapeutics performed well…
-
Local Colleges Return to In-Person on Campus, Most With Vaccinations
Several local universities are starting to enact vaccination policies for students and staff, before they can be on campus in…
-
Merck’s Cancer Antibody Granted Another Approval by FDA
Merck, the pharmaceutical giant with sizable operations in West Point, has received another approval for its blockbuster cancer antibody Keytruda,…
-
Plymouth Meeting-based Inovio Plans to Take COVID-19 Vaccine Trials Overseas
Plymouth Meeting-based Inovio Pharmaceuticals saw its stock drop by 25 percent last week. This was after the U.S. government decided…
-
West Point’s Merck Discontinues Development of Experimental COVID-19 Drug
Merck, the pharmaceutical giant with sizable operations in West Point, has decided to discontinue the development of the experimental COVID-19…
-
Plymouth Meeting-based Inovio Signs Licensing Agreement with China’s Advaccine for Its COVID-19 DNA Vaccine Candidate
Plymouth Meeting-based Inovio saw its stock jump after signing a collaboration and license agreement with Advaccine Biopharmaceuticals Suzhou for its…
-
Blue Bell-based Pinnacle 21 Seeing Business Boom Due to Demand for New Drugs, Vaccines
Blue Bell-based Pinnacle 21 is seeing demand for its services grow as companies rush to get new drugs and vaccines…
-
Plymouth Meeting-based Inovio Waiting for FDA Approval to Start COVID-19 Vaccine Trials
Plymouth Meeting-based Inovio Pharmaceuticals is waiting for approval from the FDA to start the next stage of trials for its…
-
FDA Places Clinical Hold on Plymouth Meeting’s Inovio’s COVID-19 Vaccine
The Food and Drug Administration has placed a clinical hold on Plymouth Meeting-based Inovio Pharmaceuticals’ COVID-19 vaccine, writes Justin Heinze…
-
After FDA approval, Plymouth Meeting’s Harmony Biosciences raises $50M
Plymouth Meeting-based Harmony Biosciences closed a $50 million equity financing a week after receiving its first Food and Drug Administration…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
